A phase II trial of nivolumab in advanced mucosal melanoma
Latest Information Update: 10 Jan 2019
At a glance
- Drugs Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 07 Dec 2017 Status changed from recruiting to completed.
- 08 Dec 2014 New trial record